China, Russia vaccine development offers hope to ease white-hot global vaccine scuffle
Zhao Yusha Published: Feb 03, 2021 09:22 PM
Kazakh deputy health minister Erlan Kiyasov receives Sputnik V vaccine at a local hospital in Nur-Sultan, Kazakhstan, on Feb. 1, 2021. Kazakhstan began its coronavirus vaccination campaign Monday using Russian-made Sputnik V. According to the ministry, the vaccination, carried out on a voluntary and free basis, will continue until the end of 2021 and will cover up to 6 million people. (Photo by Kalizhan Ospanov/Xinhua)
The impressive 92 percent protection rate of Russia's Sputnik V vaccine offers an opportunity for China and Russia, the two shepherds of global COVID-19 vaccine developers, to join hands on world vaccine distribution, help ease the white-hot global vaccine scuffle, and offer hope to control the pandemic, Chinese scientists said.